Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 103

1.

The influence of neonatal Bacille Calmette-Guérin (BCG) immunisation on heterologous vaccine responses in infants.

Zimmermann P, Donath S, Perrett KP, Messina NL, Ritz N, Netea MG, Flanagan KL, van der Klis FRM, Curtis N; MIS BAIR group.

Vaccine. 2019 Jun 19;37(28):3735-3744. doi: 10.1016/j.vaccine.2019.03.016. Epub 2019 May 29.

PMID:
31153688
2.

Vaccines to Children: Protective Effect and Adverse Events: A Systematic Review [Internet].

Swedish Council on Health Technology Assessment.

Stockholm: Swedish Council on Health Technology Assessment (SBU); 2009 Feb.

3.

The immunomodulatory effects of measles-mumps-rubella vaccination on persistence of heterologous vaccine responses.

Zimmermann P, Perrett KP, van der Klis FR, Curtis N.

Immunol Cell Biol. 2019 Feb 21. doi: 10.1111/imcb.12246. [Epub ahead of print]

PMID:
30791143
4.

Non-specific effect of Bacille Calmette-Guérin vaccine on the immune response to routine immunisations.

Ritz N, Mui M, Balloch A, Curtis N.

Vaccine. 2013 Jun 26;31(30):3098-103. doi: 10.1016/j.vaccine.2013.03.059. Epub 2013 Apr 10.

PMID:
23583897
5.

Bacille Calmette-Guérin (BCG) vaccination at birth and antibody responses to childhood vaccines. A randomised clinical trial.

Nissen TN, Birk NM, Smits G, Jeppesen DL, Stensballe LG, Netea MG, van der Klis F, Benn CS, Pryds O; Calmette Study Group.

Vaccine. 2017 Apr 11;35(16):2084-2091. doi: 10.1016/j.vaccine.2017.02.048. Epub 2017 Mar 15.

6.

Delayed BCG immunization does not alter antibody responses to EPI vaccines in HIV-exposed and -unexposed South African infants.

Hesseling AC, Blakney AK, Jones CE, Esser MM, de Beer C, Kuhn L, Cotton MF, Jaspan HB.

Vaccine. 2016 Jul 12;34(32):3702-9. doi: 10.1016/j.vaccine.2016.03.081. Epub 2016 Apr 4.

PMID:
27055019
7.

Non-specific immunological effects of selected routine childhood immunisations: systematic review.

Kandasamy R, Voysey M, McQuaid F, de Nie K, Ryan R, Orr O, Uhlig U, Sande C, O'Connor D, Pollard AJ.

BMJ. 2016 Oct 13;355:i5225. doi: 10.1136/bmj.i5225. Review.

8.

Immunogenicity, safety and reactogenicity of the 10-valent pneumococcal non-typeable haemophilus influenzae protein D conjugate vaccine (PHiD-CV) in Nigerian Infants: a randomised trial.

Odusanya OO, Kuyinu YA, Kehinde OA, Francois N, Yarzabal JP, Moreira M, Borys D, Schuerman L.

Niger Postgrad Med J. 2013 Dec;20(4):272-81.

PMID:
24633268
10.

Safety and immunogenicity of a toddler dose following an infant series of a hexavalent diphtheria, tetanus, acellular pertussis, inactivated poliovirus, Haemophilus influenzae type b, hepatitis B vaccine administered concurrently or at separate visits with a heptavalent pneumococcal conjugate vaccine.

Halperin SA, Tapiéro B, Dionne M, Meekison W, Diaz-Mitoma F, Zickler P, Rubin E, Embree J, Bhuyan P, Lee A, Li M, Tomovici A.

Pediatr Infect Dis J. 2014 Jan;33(1):73-80. doi: 10.1097/01.inf.0000437806.76221.20.

PMID:
24346596
11.

Antibody responses after primary immunization in infants born to women receiving a pertussis-containing vaccine during pregnancy: single arm observational study with a historical comparator.

Ladhani SN, Andrews NJ, Southern J, Jones CE, Amirthalingam G, Waight PA, England A, Matheson M, Bai X, Findlow H, Burbidge P, Thalasselis V, Hallis B, Goldblatt D, Borrow R, Heath PT, Miller E.

Clin Infect Dis. 2015 Dec 1;61(11):1637-44. doi: 10.1093/cid/civ695. Epub 2015 Sep 15. Erratum in: Clin Infect Dis. 2016 Jun 15;62(12 ):1621.

PMID:
26374816
12.

Immunological effect of administration of sequential doses of Haemophilus influenzae type b and pneumococcal conjugate vaccines in the same versus alternating limbs in the routine infant immunisation schedule: an open-label randomised controlled trial.

Iro MA, Khatami A, Marshall AS, Pace D, Voysey M, McKenna J, Campbell D, Attard-Montalto S, Finn A, White C, Faust SN, Kent A, Heath PT, MacLeod E, Stanford E, Findlow H, Almond R, Bai X, Borrow R, Snape MD, Pollard AJ.

Lancet Infect Dis. 2015 Feb;15(2):172-80. doi: 10.1016/S1473-3099(14)71057-6. Epub 2015 Jan 8.

PMID:
25577661
15.

Spotlight on DTPa-HBV-IPV/Hib Vaccine (Infanrix hexa).

Dhillon S.

BioDrugs. 2010 Oct 1;24(5):299-302. doi: 10.2165/11206690-000000000-00000. Review.

PMID:
20795752
16.

Differences in persistence of measles, mumps, rubella, diphtheria and tetanus antibodies between children with rheumatic disease and healthy controls: a retrospective cross-sectional study.

Heijstek MW, van Gageldonk PG, Berbers GA, Wulffraat NM.

Ann Rheum Dis. 2012 Jun;71(6):948-54. doi: 10.1136/annrheumdis-2011-200637. Epub 2011 Dec 15.

PMID:
22172491
17.

Acellular pertussis vaccine at birth and one month induces antibody responses by two months of age.

Wood N, McIntyre P, Marshall H, Roberton D.

Pediatr Infect Dis J. 2010 Mar;29(3):209-15. doi: 10.1097/INF.0b013e3181bc98d5.

PMID:
20009964
19.

Persistence of antibodies in 4-8 year old Austrian children after vaccination with hexavalent DTaP-HBV-IPV/Hib and MMR vaccines.

Paulke-Korinek M, Fischmeister G, Grac A, Rendi-Wagner P, Kundi M, Mohsenzadeh-Rabbani A, Moritz K, Fenninger B, Jarisch R, Jasinska J, Holzmann H, Wiedermann U, Kollaritsch H.

Vaccine. 2011 Jul 18;29(32):5130-6. doi: 10.1016/j.vaccine.2011.05.046. Epub 2011 May 30.

PMID:
21624412
20.

The effect of zinc supplementation during pregnancy on immune response to Hib and BCG vaccines in Bangladesh.

Osendarp SJ, Fuchs GJ, van Raaij JM, Mahmud H, Tofail F, Black RE, Prabhakar H, Santosham M.

J Trop Pediatr. 2006 Oct;52(5):316-23. Epub 2006 Apr 18.

PMID:
16621858

Supplemental Content

Support Center